• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Quality

    FDA recall of Medtronic embolization devices as `most serious`

    REUTERS

    Medtronic recalls MiniMed insulin pumps over drained batteries

    FIERCE BIOTECH

    Medtronic Recalls MiniMed Pumps Due To Battery Life Risk

    PHARMABIZ

    Medtronic recalls nerve monitoring tech linked to 10 patient injuries

    FIERCE BIOTECH

    FDA boosts Medtronic recall of brain surgery navigation software

    FIERCE BIOTECH

    Medtronic recalls 348K implantable defibrillators in the US

    FIERCE BIOTECH

    Medtronic Recalls Cardiac Defibrillators Due To Reduced Shock Potential

    MEDTECH INSIGHT

    FDA slaps Class I label on Medtronic latest heart pump recall

    FIERCEBIOTECH

    Medtronic’s Covidien has another Class I recall for PB980 ventilators

    MEDTECHDIVE

    Medtronic recalls StealthStation neurosurgery software, again

    FIERCEBIOTECH

    Medtronic’s diabetes HQ receives FDA warning letter

    KPVI

    Medtronic’s Covidien faces another Class I ventilator recall

    FIERCEBIOTECH

    Medtronic expands two Class I recalls of MiniMed insulin pumps

    MEDCITYNEWS

    U.S. Patent and Trademark Office Rejects Axonics` Challenge to Medtronic Patents

    BIOSPACE

    Medtronic recalls unsterilized angiography guidewires

    FIERCEBIOTECH

    Medtronic recalls aortic stent graft implant after patient death

    FIERCEBIOTECH

    Medtronic recommends physicians to continue patient follow-up with pacemakers

    NPR

    FDA, DHS Alert to Cybersecurity Flaws Affecting Medtronic Cardiac Devices

    RAPS

    Three MNC pharma companies want to recall its new generation stents from India

    ECONOMIC TIMES

    FDA Designates Medtronic Worldwide Voluntary Field Action&DC as Class I Recall

    NEWSROOM

    Medtronic Issues Recall for Certain Neurovascular Products

    WALL STREET JOURNAL

    IPO Releases List of Top 300 Patent Holders for 2014

    PATENT DOCS

    Federal Courts Erroneously Continue to Claim that FDA Only Spends 20 Hours On Average Reviewing 510(k)s

    FDA LAW BLOG

    FDA enters consent decree with Medtronic, Inc.

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.